http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2295280-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2544aacca90e3ac253293390034c093c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a2aec245a4134d2a2142ffc0a6233d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcf53c818359d3bb8fcea82a94959136
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
filingDate 2005-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b342d299c6813f7cb1cc05daeae7b76e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73b7cad20c1528dc1ef0e2be3da8aaf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9619e8e6ef3227a31768ed34f002ac1
publicationDate 2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2295280-C1
titleOfInvention Method for increasing optic functions in children with inborn optic nystagmus
abstract FIELD: medicine, neuroophthalmology. n SUBSTANCE: it is necessary to register electroencephalogram (EEG) and at disorganized low-amplitude EEG, when amplitude of alpha-rhythm is below 30 mcV or is not detected at all it is necessary to prescribe nystenon per os per 1 tablet twice/d daily for 2 wk. In case of high-amplitude hypersynchronous EEG at amplitude of alpha-rhythm being 100 mcV and more one should prescribe glycin per 1 tablet 100 mg sublingually twice/d daily for 2 wk. Then comes video-training with the help of "Amblyocor-01" device for 2 wk along with simultaneous intake of earlier prescribed preparations. In case of disorganized low-amplitude EEG one should fulfill training in the mode of "relaxation", in case of high-amplitude hypersynchronous EEG - in the mode of "activation". The innovation enables to affect central departments of optic analyzer. n EFFECT: higher efficiency of correction. n 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2583774-C2
priorityDate 2005-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407866699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414865193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3080653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448171514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9651
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5777

Total number of triples: 32.